CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2023		105,209,000
Balance at beginning of period at Dec. 31, 2023	$ 1,588,351	$ 105	$ 1,354,703	$ (32,626)	$ 266,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	63,701				63,701
Other comprehensive income (loss)	(11,379)			(11,379)
Dividends declared	(56,382)				(56,382)
Net issuances of restricted stock (in shares)		751,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	16,777		16,777
Repurchases of common stock (in shares)		(1,028,000)
Repurchases of common stock	(81,823)	$ (1)			(81,822)
Balance at ending of period (in shares) at Mar. 31, 2024		104,932,000
Balance at end of period at Mar. 31, 2024	1,519,245	$ 105	1,371,479	(44,005)	191,666
Balance at beginning of period (in shares) at Dec. 31, 2023		105,209,000
Balance at beginning of period at Dec. 31, 2023	1,588,351	$ 105	1,354,703	(32,626)	266,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	197,308
Other comprehensive income (loss)	(835)
Balance at ending of period (in shares) at Sep. 30, 2024		103,247,000
Balance at end of period at Sep. 30, 2024	1,473,835	$ 103	1,402,817	(33,461)	104,376
Balance at beginning of period (in shares) at Mar. 31, 2024		104,932,000
Balance at beginning of period at Mar. 31, 2024	1,519,245	$ 105	1,371,479	(44,005)	191,666
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	68,156				68,156
Other comprehensive income (loss)	(6,586)			(6,586)
Dividends declared	(55,407)				(55,407)
Net issuances of restricted stock (in shares)		27,000
Stock-based compensation	15,631		15,631
Repurchases of common stock (in shares)		(903,000)
Repurchases of common stock	(60,884)	$ (1)			(60,883)
Balance at ending of period (in shares) at Jun. 30, 2024		104,056,000
Balance at end of period at Jun. 30, 2024	1,480,155	$ 104	1,387,110	(50,591)	143,532
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	65,451				65,451
Other comprehensive income (loss)	17,130			17,130
Dividends declared	(54,760)				(54,760)
Net issuances of restricted stock (in shares)		(8,000)
Stock-based compensation	15,707		15,707
Repurchases of common stock (in shares)		(801,000)
Repurchases of common stock	(49,848)	$ (1)			(49,847)
Balance at ending of period (in shares) at Sep. 30, 2024		103,247,000
Balance at end of period at Sep. 30, 2024	$ 1,473,835	$ 103	1,402,817	(33,461)	104,376
Balance at beginning of period (in shares) at Dec. 31, 2024	102,199,470	102,199,000
Balance at beginning of period at Dec. 31, 2024	$ 1,378,003	$ 102	1,418,150	(65,138)	24,889
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	17,350				17,350
Other comprehensive income (loss)	11,472			11,472
Dividends declared	(60,163)		(60,163)
Net issuances of restricted stock (in shares)		823,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	16,705		16,705
Repurchases of common stock (in shares)		(858,000)
Repurchases of common stock	(50,145)	$ (1)	(7,905)		(42,239)
Balance at ending of period (in shares) at Mar. 31, 2025		102,164,000
Balance at end of period at Mar. 31, 2025	$ 1,313,222	$ 102	1,366,786	(53,666)	0
Balance at beginning of period (in shares) at Dec. 31, 2024	102,199,470	102,199,000
Balance at beginning of period at Dec. 31, 2024	$ 1,378,003	$ 102	1,418,150	(65,138)	24,889
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	101,234
Other comprehensive income (loss)	$ 32,565
Balance at ending of period (in shares) at Sep. 30, 2025	101,161,069	101,161,000
Balance at end of period at Sep. 30, 2025	$ 1,286,092	$ 101	1,318,564	(32,573)	0
Balance at beginning of period (in shares) at Mar. 31, 2025		102,164,000
Balance at beginning of period at Mar. 31, 2025	1,313,222	$ 102	1,366,786	(53,666)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	40,968				40,968
Other comprehensive income (loss)	23,639			23,639
Dividends declared			(39,473)
Dividends declared	(60,284)				(20,811)
Net issuances of restricted stock (in shares)		36,000
Stock-based compensation	14,530		14,530
Repurchases of common stock (in shares)		(461,000)
Repurchases of common stock	(20,157)				(20,157)
Balance at ending of period (in shares) at Jun. 30, 2025		101,739,000
Balance at end of period at Jun. 30, 2025	1,311,918	$ 102	1,341,843	(30,027)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	42,916				42,916
Other comprehensive income (loss)	(2,546)			(2,546)
Dividends declared			(37,197)
Dividends declared	(59,873)				(22,676)
Net issuances of restricted stock (in shares)		(3,000)
Stock-based compensation	13,918		13,918
Repurchases of common stock (in shares)		(575,000)
Repurchases of common stock	$ (20,241)	$ (1)			(20,240)
Balance at ending of period (in shares) at Sep. 30, 2025	101,161,069	101,161,000
Balance at end of period at Sep. 30, 2025	$ 1,286,092	$ 101	$ 1,318,564	$ (32,573)	$ 0